Related Experiment Videos
Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: a six-year study
P H Juergensen1, F O Finkelstein, R Brennan
1Department of Medicine, Hospital of St. Raphael, New Haven, CT.
Summary
Pseudomonas aeruginosa peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients is difficult to treat with medication alone. Prompt removal of the peritoneal dialysis catheter is essential for infection resolution and preventing complications.
Area of Science:
- Nephrology
- Infectious Diseases
- Medical Technology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a common treatment for end-stage renal disease.
- Peritonitis is a serious complication of CAPD, with Pseudomonas aeruginosa being a challenging pathogen.
- Previous treatment strategies for Pseudomonas peritonitis in CAPD have shown limited success.
Purpose of the Study:
- To evaluate the efficacy of medical therapy versus catheter removal in treating Pseudomonas aeruginosa peritonitis in CAPD patients.
- To identify the key factors influencing treatment outcomes and patient morbidity.
- To provide recommendations for managing this specific type of infection.
Main Methods:
- Retrospective analysis of 415 peritoneal infections in 214 CAPD patients from 1980 to 1986.
- Focus on 14 cases of Pseudomonas aeruginosa peritonitis.
- Comparison of treatment outcomes based on medical therapy alone versus catheter removal.
Main Results:
- Pseudomonas aeruginosa caused 3.4% of peritonitis cases (14 out of 415).
- No patients achieved cure with medical therapy alone; all required catheter removal for resolution.
- Significant patient morbidity included loss of peritoneal space and abscess formation.
Conclusions:
- Pseudomonas aeruginosa peritonitis in CAPD patients is refractory to medical treatment alone.
- Peritoneal catheter removal is crucial for successful infection management.
- Prompt catheter removal should be strongly considered to prevent severe patient morbidity.